AC Immune SA
Novel Compounds for the Treatment, Alleviation or Prevention of Disorders Associated with Tau Aggregates

Last updated:

Abstract:

The present invention relates to novel compounds of formula (I) that can be employed in the treatment, alleviation or prevention of a group of disorders and abnormalities associated with Tau (Tubulin associated unit) protein aggregates including, but not limited to, Neurofibrillary Tangles (NFTs), such as Alzheimer's disease (AD). ##STR00001##

Status:
Application
Type:

Utility

Filling date:

30 May 2019

Issue date:

2 Sep 2021